Clinical Trial Update: Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans [NA]

View source ↗

Summary

Completed clinical trial evaluating the effect of dietary advanced glycation end-products on insulin resistance in overweight and obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Bayside Health | Conditions: Type 2 Diabetes, Insulin Resistance | NA | Status: COMPLETED